117 related articles for article (PubMed ID: 11592634)
1. Plasminogen activator production in a rat model of Pneumocystis carinii pneumonia.
Angelici E; Contini C; Spezzano M; Romani R; Carfagna P; Serra P; Canipari R
Microbiol Immunol; 2001; 45(8):605-11. PubMed ID: 11592634
[TBL] [Abstract][Full Text] [Related]
2. Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without P. Jiroveci infection.
Angelici E; Spezzano M; Vaccari S; Valentini SB; Romani R; Contini C; Canipari R
Microb Pathog; 2006 Jul; 41(1):1-9. PubMed ID: 16704917
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice.
Beck JM; Preston AM; Gyetko MR
Infect Immun; 1999 Feb; 67(2):879-84. PubMed ID: 9916103
[TBL] [Abstract][Full Text] [Related]
4. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH
Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457
[TBL] [Abstract][Full Text] [Related]
5. Production of plasminogen activator by alveolar macrophages in experimental Pneumocystis carinii pneumonia.
Angelici E; Contini C; Spezzano M; Romani R; Carfagna P; Serra P; Canipari R
J Eukaryot Microbiol; 1999; 46(5):149S. PubMed ID: 10519296
[No Abstract] [Full Text] [Related]
6. Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages.
Lasbury ME; Lin P; Tschang D; Durant PJ; Lee CH
Infect Immun; 2004 Apr; 72(4):2140-7. PubMed ID: 15039336
[TBL] [Abstract][Full Text] [Related]
7. Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro.
Koziel H; Li X; Armstrong MY; Richards FF; Rose RM
Am J Respir Cell Mol Biol; 2000 Oct; 23(4):452-9. PubMed ID: 11017909
[TBL] [Abstract][Full Text] [Related]
8. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia.
Lasbury ME; Durant PJ; Ray CA; Tschang D; Schwendener R; Lee CH
J Immunol; 2006 Jun; 176(11):6443-53. PubMed ID: 16709801
[TBL] [Abstract][Full Text] [Related]
9. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacies of chitosan against Pneumocystis pneumonia of immunosuppressed rat.
Liu AB; Pu Y; Zheng YQ; Cai H; Ye B
Parasite Immunol; 2014 Jul; 36(7):292-302. PubMed ID: 24702055
[TBL] [Abstract][Full Text] [Related]
11. Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without Pneumocystis carinii.
Angelici E; Contini C; Carfagna P; Romani R; Magno MS; Serra P; Canipari R
J Eukaryot Microbiol; 2001; Suppl():150S-151S. PubMed ID: 11906036
[No Abstract] [Full Text] [Related]
12. Effect of CD40 ligand and other immunomodulators on Pneumocystis carinii infection in rat model.
Oz HS; Hughes WT; Rehg JE; Thomas EK
Microb Pathog; 2000 Sep; 29(3):187-90. PubMed ID: 10968950
[TBL] [Abstract][Full Text] [Related]
13. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.
Lasbury ME; Tang X; Durant PJ; Lee CH
Infect Immun; 2003 Sep; 71(9):4943-52. PubMed ID: 12933836
[TBL] [Abstract][Full Text] [Related]
14. Changes in alveolar macrophage number are early events in Pneumocystis carinii infection.
Lasbury ME; Durant PJ; Lee CH
J Eukaryot Microbiol; 2001; Suppl():161S-162S. PubMed ID: 11906044
[No Abstract] [Full Text] [Related]
15. Pneumocystis carinii induction of tumor necrosis factor-alpha by alveolar macrophages: modulation by pentamidine isethionate.
Corsini E; Dykstra C; Craig WA; Tidwell RR; Rosenthal GJ
Immunol Lett; 1992 Dec; 34(3):303-8. PubMed ID: 1487315
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the burden of Pneumocystis carinii, the inflammatory reaction and lung injury in Pneumocystis carinii pneumonia.
Qu J; Rong Z; He L; Pan J; Chen X
Chin Med J (Engl); 2000 Dec; 113(12):1071-4. PubMed ID: 11776138
[TBL] [Abstract][Full Text] [Related]
17. Effect of corticosteroids on IL1 beta and TNF alpha release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia.
Huang ZB; Eden E
Chest; 1993 Sep; 104(3):751-5. PubMed ID: 8365285
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of urokinase in alveolar macrophages and lung tissue in response to silica particles.
Lardot C; Delos M; Lison D
Am J Physiol; 1998 Jun; 274(6):L1040-8. PubMed ID: 9609744
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages.
Castro M; Morgenthaler TI; Hoffman OA; Standing JE; Rohrbach MS; Limper AH
Am J Respir Cell Mol Biol; 1993 Jul; 9(1):73-81. PubMed ID: 8393326
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat.
Phelps DS; Umstead TM; Rose RM; Fishman JA
Eur Respir J; 1996 Mar; 9(3):565-70. PubMed ID: 8730021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
